Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 475
Last updated 2015-01-09
Summary
The primary objective is to identify a panel of plasma and/or serum proteins that differentiates the absence or presence of lung malignancy in samples obtained from subjects enrolled in this IRB/EC approved study with pulmonary nodules.
Conditions
- Precancerous Conditions
- Carcinoma
Sponsors & Collaborators
-
Integrated Diagnostics
lead INDUSTRY
Principal Investigators
-
Russell F. Hudnall · Integrated Diagnostics, Inc.
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Detection of Early Lung Cancer by Serum Protein Expression Profiling
NCT00175578 ·Status: UNKNOWN
-
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT01928836 ·Status: COMPLETED
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
NCT06816121 ·Status: RECRUITING
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING
-
A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.
NCT06733311 ·Status: RECRUITING
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer
NCT01958931 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077 ·Status: RECRUITING
-
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
NCT06778512 ·Status: RECRUITING
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
NCT01415739 ·Status: WITHDRAWN
-
A Multi-Center Trial of the ProLung Test™
NCT01566682 ·Status: COMPLETED
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Molecular and Genetic Analysis of Lung Cancer
NCT03029325 ·Status: RECRUITING
-
Diagnostic Study for Lung Cancer Detection Test
NCT01700452 ·Status: COMPLETED
-
Detection of Lung Cancer by Plasma Lipids
NCT04287712 ·Status: COMPLETED